Dissertation > Excellent graduate degree dissertation topics show

Detection and Clinical Significance of Circulating Tumor Cells and Tumor Stem Cells in Patients with Primary Breast Cancer

Author: WangMeng
Tutor: LiuYunJiang
School: Hebei Medical University
Course: Surgery
Keywords: breast cancer peripheral blood micrometastases circulating tumor cells tumor stem cells CD44+/CD24—/low MACS
CLC: R737.9
Type: Master's thesis
Year: 2011
Downloads: 113
Quote: 0
Read: Download Dissertation

Abstract


Objective: To detect circulating tumor cells（CTC） and tumor stem cells（TSC） in patients with primary breast cancer, and evaluate the relation between CTC and clinical pathology.Methods:1 Peripheral blood samples（10 ml in EDTA） from 44 patients with primary breast cancer and from 15 healthy volunteers were prepared for Peripheral blood mononuclear cells（PBMC）.2 PBMC were incubated with cytokeratins 19（CK19） mouse monoclonal antibodies, as the marker of circulating tumor cells （CTC）.3 The cells were selected with Magnetic-activated cell sorting（MACS） for positive selection of cytokeratin-19-positive (CK19+)cells.4 A double immunohistochemical staining was applied on the CK19+ cells using the anti-CD44 mouse monoclonal antibodies and anti-CD24 mouse monoclonal antibodies, detection of CD44+/CD24—/low cells as the marker of tumor stem cells（TSC）.5 Selected the CD44+/CD24—/low cells using fluorescence microscope.6 The data was analyzed with SPSS13.0 statistical software.Results:1 There was no CK19 positive cells in peripheral blood of 15 healthy volunteers. Detection of 44 patients with primary breast cancer showed that 33 of 44（75.00%） patients had CK19 positive cells in PBMC. It showed statistical difference between tow groups（P< 0.05）.2 44 patients were divided into three groups based on the TNM system, 5 of 12（41.67%） samples in stageⅠ, 15 of 18（83.33%） samples in stageⅡand 13 of 14（92.86%） samples in stageⅢhad CK19 positive cells. It showed statistical difference between different clinical stage（P< 0.05）. 3 44 samples were divided into two groups based on lymph node metastasis, 15 of 24（62.50%） in N0 and 18 of 20（90.00%） in N1-3 had CK19 positive cells. It showed statistical difference between different clinical stage（P< 0.05）.4 CD44+/CD24—/low cells were detected in 21 of 33 （63.63%） patients who had CK19 positive cells in peripheral blood. Three groups were divided based on the TNM system, 2 of 5（40.00%） samples in stageⅠ, 10 of 15（66.67%） samples in stageⅡand 9 of 13（69.23%）samples in stageⅢhad CD44+/CD24—/low cells.5 24 of 33（72.73%） found CK19 positive cells in ER-positive samples, 15 of 24（62.50%） samples found CD44+/CD24—/low cells; 9 of 11（81.82%） found CK19 positive cells in ER-negative samples, 6 of 9（66.67%） samples found CD44+/CD24—/low cells.6 4 of 6（66.67%） found CK19 positive cells in C-erbB2 positive samples, 2 of 4（50.00%） samples found CD44+/CD24—/low cells; 16 of 24（66.67%） found CK19 positive cells in C-erbB2 negative samples, 11 of 16（68.75%） samples found CD44+/CD24—/low cells.7 9 of 13（69.23%） found CK19 positive cells in angiolymphatic invasion samples, 8 of 9（88.89%） samples found CD44+/CD24—/low cells; 24 of 31（77.42%） found CK19 positive cells in non-angiolymphatic-invasion samples, 13 of 24（54.17%） samples found CD44+/CD24—/low cells.8 All cases had been classified into 3 subgroups （triple-negative, ER- positive, and C-erbB2 positive） based on gene expression profiles. 5 of 5（100.00%） found CK19 positive cells in triple-negative samples, 4 of 5（80.00%） samples found CD44+/CD24—/low cells; 11 of 19（57.89%） found CK19 positive cells in ER-positive samples, 7 of 11（63.64%） samples found CD44+/CD24—/low cells; 3 of 4（75.00%） found CK19 positive cells in C-erbB2 positive samples, 2 of 3（66.67%） samples found CD44+/CD24—/low cells.Conclusion:1 CTC and TSC can be detected in peripheral blood from patient with primary breast cancer.2 The ratio of CTC is related to clinical stage and metastastc lymph node. 3 TSC is related to clinical stage, and there are more TSC in later stage patients than eraly stage patients.4 The ratio of CTC and TSC is related tuo ER, PR, C-erbB2, angiolymphatic invasion and gene expression profiles.

Related Dissertations

  1. The Effects of Pu-erh Tea on Prevetion and Treatment of Tumor,R285.5
  2. The Related Study of Breast-conserving Surgery Plus Postoperative Tangential Irradiation,R737.9
  3. The Relevance Research between Breast Cancer Calcification X Performance and Pathology,R737.9
  4. Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
  5. The Contribution of the CCl22, CCR4 in the Milky Spots Peritoneal -metastasis of Gastric Cancer,R735.2
  6. The Correlation of Ultrasound Elasticity with the Expressions of Estrogen Receptor, Progestron Receptor, C-erbB-2 in Breast Cancer,R445.1
  7. Research of Differentiation of Human Peripheral Blood Mononuclear Cells into Hepatocyte-like Cells in Vitro,R575.3
  8. Study on Human Peripheral Blood Stem Cells Differentiate into Liver Cells,R575.1
  9. Expressions of HOXA9 HOXA10 and HOXA11 in Breast Cancer,R737.9
  10. The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9
  11. The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
  12. Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
  13. The Expression and Significance of Parathyroid Hormone-related Protein in Human Breast Cancer with Skeletal Metastases,R737.9
  14. The Shrink Pattern of Breast Cancer After Neoadjuvant Chemotherapy and the Correlation with Partial Clinic Pathological Factors: Preliminary Results of a Plot Study,R737.9
  15. Analysis of Clinial and Patholgoic Characteristics between the Han and the Uygur Patients with Triple-negative Breast Cancer,R737.9
  16. Clinical Signifinance of Combined Detection of Tumor Markers in Breast Cancer,R737.9
  17. Isoflavone intake and the risk of breast and prostate cancer Meta-analysis,R737.25
  18. Mammographic X-ray analysis of false-negative breast cancer,R737.9
  19. Epidermal growth factor in breast carcinoma and its clinical significance 1,2,R737.9
  20. CK5 / 6 and EGFR as triple negative breast cancer prognostic factors analysis,R737.9
  21. Expression of PD-1 on T Lymphocytes and PD-L1 on Peripheral Blood Mononuclear Cells from the Patients with Systemic Lupus Erythematosus,R593.241

CLC: > Medicine, health > Oncology > Genitourinary tumors > Breast tumor
© 2012 www.DissertationTopic.Net  Mobile